γ‐Tocotrienol enhances autophagy of gastric cancer cells by the regulation of GSK3β/β‐Catenin pathway
Molecular Carcinogenesis · 2024-10 · 63 (10) · 2013-2025
DOI: 10.1002/mc.23790 ↗At a glance
Journal article in Molecular Carcinogenesis, published online on 2024-07-09. Written by Hao Zhu and 8 co-authors. Institution: Department of Clinical Laboratory, The Forth Affiliated Hospital of Harbin Medical University, Harbin, China. Major MEDLINE topics: Stomach Neoplasms, Autophagy, Glycogen Synthase Kinase 3 beta, beta Catenin. Cited 6 times so far (Crossref); 32 references. Funded by: Project of Research and Innovation of Harbin Medical University, National Natural Science Fund.
Abstract (original language)
γ‐Tocotrienol (γ‐T3) is a major subtype of vitamin E, mainly extracted from palm trees, barley, walnuts, and other plants. γ‐T3 has effects on anti‐inflammation, anti‐oxidation, and potential chemoprevention against malignancies. It is still uncompleted to understand the effect of γ‐T3 on the inhibitory mechanism of cancer. This study aimed to investigate whether γ‐T3 enhanced autophagy in gastric cancer and the underlying molecular mechanism. The results showed that γ‐T3 (0–90 μmol/L) inhibited the proliferation of gastric cancer MKN45 cells and AGS cells, and arrested the cell cycle at the G0/G1 phase in a dose‐dependent manner. Autophagy was increased in MKN45 cells treated with γ‐T3 (0–45 μmol/L), especially at a dose of 30 μmol/L for 24 h. These effects were reversed by 3‐methyladenine pretreatment. Furthermore, γ‐T3 (30 μmol/L) also significantly downregulated the expression of pGSK‐3β (ser9) and β‐catenin protein in MKN45 cells, and γ‐T3 (20 mg/kg b.w.) effectively decreased the growth of MKN45 cell xenografts in BABL/c mice. GSK‐3β inhibitor‐CHIR‐99021 reversed the negative regulation of GSK‐3β/β‐Catenin signaling and autophagy. Our findings indicated that γ‐T3 enhances autophagy in gastric cancer cells mediated by GSK‐3β/β‐Catenin signaling, which provides new insights into the role of γ‐T3 enhancing autophagy in gastric cancer.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Department of Clinical Laboratory, The Forth Affiliated Hospital of Harbin Medical University, Harbin, China.
- Department of Endoncrology, The Second Affiliated Hospital of Harbin Medical University, Harbin, China.
- Department of Cardiovascular Ultrasound, Harbin, China.
- College of Public Health, Harbin Medical University, Harbin, China.
- International Peace Maternity and Child Health Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
ORCID profiles: Hao Zhu, Jia-Ren Liu
Funding
- Project of Research and Innovation of Harbin Medical University
- National Natural Science Fund
Cite
APA
Zhu, H., Wang, F. L., Zhang, S., Xue, L., Gao, G. Q., Dong, H. W., Wang, Q., Sun, W. G., & Liu, J. R. (2024). γ‐Tocotrienol enhances autophagy of gastric cancer cells by the regulation of GSK3β/β‐Catenin pathway. Molecular Carcinogenesis, 63(10), 2013-2025. https://doi.org/10.1002/mc.23790
Vancouver
Zhu H, Wang FL, Zhang S, Xue L, Gao GQ, Dong HW, et al. γ‐Tocotrienol enhances autophagy of gastric cancer cells by the regulation of GSK3β/β‐Catenin pathway. Molecular Carcinogenesis. 2024;63(10):2013-2025. doi:10.1002/mc.23790
BibTeX
@article{Zhu2024,
author = {Zhu, Hao and Wang, Fa-Lin and Zhang, Shuang and Xue, Li and Gao, Guang-Qiang and Dong, Hong-Wei and Wang, Qi and Sun, Wen-Guang and Liu, Jia-Ren},
title = {γ‐Tocotrienol enhances autophagy of gastric cancer cells by the regulation of GSK3β/β‐Catenin pathway},
journal = {Molecular Carcinogenesis},
year = {2024},
volume = {63},
number = {10},
pages = {2013--2025},
doi = {10.1002/mc.23790}
}
EUVIMED